Thalidomide, a current teratogen in South America

Teratology

Volumn 54, Issue 6, 1996, Pages 273-277

  Castilla, E E ^a,b   Ashton Prolla, P ^s   Barreda Mejia, E ^e   Brunoni, D ^f   Cavalcanti, D P ^g   Correa Neto, J ^d   Delgadillo, J L ^h   Dutra, M G ^a   Felix, T ⁱ   Giraldo, A ^j   Juarez, N ^k   Lopez Camelo, J S ^c   Nazer, J ^l   Orioli, I M ^m   Paz, J E ^b,c   Pessoto, M A ^g   Pina Neto, J M ⁱ   Quadrelli, R ⁿ   Rittler, M ^o   Rueda, S ^p   Saltos, M ^q   Sanchez O ^r   Schuler L ^s   more..

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b CEMIC   (Argentina)

^c Instituto Multidisciplinario de Biologia Celular   (Argentina)

^d Associacao Assistencia Crianca D   (Brazil)

^e Centro de Endometriosis y Dolor Pélvico   (Peru)

^f FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^g UNIVERSITY OF CAMPINAS   (Brazil)

^h HOSPITAL DE CLÍNICAS   (Paraguay)

ⁱ UNIVERSITY OF SÃO PAULO   (Brazil)

^j Fundacion Arthur Stanley Gillow   (Colombia)

^k Hospital de Ninos de la Santisima Trinidad   (Argentina)

^l HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^m FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

ⁿ Hospital Italiano Montevideo   (Uruguay)

^o Hospital Materno Infantil Ramon Sarda   (Argentina)

^p Maternidad Natalio Aramayo   (Bolivia)

^q Hospital Rodriguez Zambrano   (Ecuador)

^r Hosp Univ Ruiz y Páez   (Venezuela)

^s HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL TERATOGEN; LEPROSTATIC AGENT; THALIDOMIDE; TERATOGENIC AGENT;

ARTICLE; CLINICAL ARTICLE; DRUG USE; EMBRYO; EMBRYOPATHY; FEMALE; HUMAN; LEPROSY; MALE; PHOCOMELIA; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SOUTH AMERICA; TERATOGENICITY; CONGENITAL MALFORMATION; NEWBORN;

ABNORMALITIES, DRUG-INDUCED; FEMALE; HUMANS; INFANT, NEWBORN; LEPROSTATIC AGENTS; LEPROSY; MALE; PREGNANCY; SOUTH AMERICA; TERATOGENS; THALIDOMIDE;

EID: 0030299068     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-9926(199612)54:6<273::aid-tera1>3.0.co;2-%23     Document Type: Article

References (17)

1. Calzolari, E., D. Maservigi, G.P. Garani, G. Cocchi, C. Magnani, and M. Milan (1990) Limb reduction defects in Emilia Romagna, Italy: Eoidemiologic and genetic study in 173,109 consecutive births. J. Med. Genet., 27:353-357.
2. Castilla, E.E., and J.S. Lopez-Camelo (1990): The surveillance of birth defects in South America:-I-The search for time clusters: Epidemics. Adv. Mutagen. Res., 2:191-210.
3. Castilla, E.E., D.P. Cavalcanti, M.G. Dutra, J.S. Lopez-Camelo, J.E. Paz, and B.C. Gadow (1995) Limb reduction defects in South America. Br. J. Obstet. Gynecol., 102:393-400.
4. D'Amato, R.J., M.S. Luoghnan, E Flynn, and J. Folkman (1994) Thalidomide is an inhibitor of angiogenesis. Proc. Natl. Acad. Sci. U.S.A., 91:4082-4085.
5. Erickson, J.D. (1965) Thalidomide use on the rise. Teratol. Soc. Newsl., 8:5.
6. Froster-Iskenius, U.G., and P.A. Baird (1989) Limb reduction defects in over one million consecutive live births. Teratology, 39:127-135.
7. Gollop, T.R., A. Eigier, and J. Guidugli-Neto (1987) Prenatal diagnosis of thalidomide syndrome. Prenat. Diagn., 7:295-298.
8. German, C. (1994) Thalidomide's return. Time, June 13, p. 47.
9. Källén, B., T.M.Z. Rahmani, and J. Wienberg (1984) Infants with congenital limb reduction registered in the Sweden Register of Congenital Malformations. Teratology, 29:73-85.
10. Kida, M. (1994) Thalidomide may not be a mutagen. Br. Med. J., 309:741.
11. Lin, S., E.G. Marshall, G.K. Davidson, G.B. Roth, and C.M. Druschel (1993) Evaluation of congenital limb reduction defects in Upstate New York. Teratology, 47:127-135.
12. McBride, W.G. (1994) Thalidomide may be a mutagen. Br. Med. J., 308:1635-1636.
13. OPS/OMS (1994) Las Condiciones de Salud en las Americas. Organizacion Panamericana de la Salud, Washington, DC, Vol. 1.
14. Read, A. (1994) Thalidomide may be a mutagen. Br. Med. J., 308:1636.
15. Rocha, J. (1994) Thalidomide given to women in Brazil. Br. Med. J., 308:1061.
16. Schmidt, M., and F.M. Salzano (1983) Clinical studies on teenage Brazilian victims of thalidomide. Brazil. J. Med. Biol. Res., 16:105-109.
17. Smithells, R.W., and C.G.H. Newman (1992) Recognition of thalidomide defects (syndrome of the month). J. Med. Genet., 29:716-723.